197 related articles for article (PubMed ID: 19789647)
1. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.
Green JA; Tran CT; Farrar JJ; Nguyen MT; Nguyen PH; Dinh SX; Ho ND; Ly CV; Tran HT; Friedland JS; Thwaites GE
PLoS One; 2009 Sep; 4(9):e7277. PubMed ID: 19789647
[TBL] [Abstract][Full Text] [Related]
2. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.
Mai NTH; Dobbs N; Phu NH; Colas RA; Thao LTP; Thuong NTT; Nghia HDT; Hanh NHH; Hang NT; Heemskerk AD; Day JN; Ly L; Thu DDA; Merson L; Kestelyn E; Wolbers M; Geskus R; Summers D; Chau NVV; Dalli J; Thwaites GE
Elife; 2018 Feb; 7():. PubMed ID: 29482717
[TBL] [Abstract][Full Text] [Related]
3. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.
Colas RA; Nhat LTH; Thuong NTT; Gómez EA; Ly L; Thanh HH; Mai NTH; Phu NH; Thwaites GE; Dalli J
FASEB J; 2019 Nov; 33(11):13028-13039. PubMed ID: 31500466
[TBL] [Abstract][Full Text] [Related]
4. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
5. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
[TBL] [Abstract][Full Text] [Related]
6. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Majeed S; Singh P; Sharma N; Sharma S
BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
[TBL] [Abstract][Full Text] [Related]
7. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
Simmons CP; Thwaites GE; Quyen NT; Chau TT; Mai PP; Dung NT; Stepniewska K; White NJ; Hien TT; Farrar J
J Immunol; 2005 Jul; 175(1):579-90. PubMed ID: 15972695
[TBL] [Abstract][Full Text] [Related]
8. Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
van Laarhoven A; Dian S; Ruesen C; Hayati E; Damen MSMA; Annisa J; Chaidir L; Ruslami R; Achmad TH; Netea MG; Alisjahbana B; Rizal Ganiem A; van Crevel R
J Infect Dis; 2017 Apr; 215(7):1029-1039. PubMed ID: 28419315
[TBL] [Abstract][Full Text] [Related]
9. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Thwaites G; Fisher M; Hemingway C; Scott G; Solomon T; Innes J;
J Infect; 2009 Sep; 59(3):167-87. PubMed ID: 19643501
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis.
Majeed S; Radotra BD; Sharma S
Int J Exp Pathol; 2016 Jun; 97(3):230-7. PubMed ID: 27385155
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal cerebrospinal fluid assessment in a patient with tuberculous meningitis-A case report.
Chen Y; Liu X; Zhang X; Zhang Z; Zhou X; Wang Y; Wu S; Zheng L
J Clin Lab Anal; 2020 Jul; 34(7):e23286. PubMed ID: 32159262
[TBL] [Abstract][Full Text] [Related]
12. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Lee KY; Kim EH; Yang WS; Ryu H; Cho SN; Lee BI; Heo JH
J Neurol Sci; 2004 May; 220(1-2):73-8. PubMed ID: 15140609
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intrathecal dexamethasone combined with isoniazid in the treatment of tuberculous meningitis: a meta-analysis.
Gao Y; Su J; Ma Y; Sun Y; Cui J; Jin X; Li Y; Chen Z
BMC Neurol; 2024 Jun; 24(1):194. PubMed ID: 38858618
[TBL] [Abstract][Full Text] [Related]
14. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
Trials; 2011 Feb; 12():25. PubMed ID: 21288325
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.
Török ME; Nguyen DB; Tran TH; Nguyen TB; Thwaites GE; Hoang TQ; Nguyen HD; Tran TH; Nguyen TC; Hoang HT; Wolbers M; Farrar JJ
PLoS One; 2011; 6(12):e27821. PubMed ID: 22174748
[TBL] [Abstract][Full Text] [Related]
18. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro.
Zeni P; Doepker E; Schulze-Topphoff U; Huewel S; Tenenbaum T; Galla HJ
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C855-64. PubMed ID: 17507431
[TBL] [Abstract][Full Text] [Related]
19. Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis.
Ong CW; Pabisiak PJ; Brilha S; Singh P; Roncaroli F; Elkington PT; Friedland JS
J Neuroinflammation; 2017 Feb; 14(1):31. PubMed ID: 28173836
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
